drugset / Trial / NCT01060345
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to find molecular signs (biomarkers) to better understand the role of green tea as an anti-cancer and anti-inflammation agent in women with newly-diagnosed ductal carcinoma in situ (DCIS).
Timeline
- Start
- 2010-05
- Primary completion
- 2015-09
- Completion
- 2015-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sinecatechins | Unknown | 600 mg | Oral |